13F HOLDINGS REPORT
Springhill Fund Asset Management (HK) Co Ltd
Quarter ended Q1 2025 · Filed May 14, 2025 · Accession 0001911270-25-000003
Total Value
$20.9M
Positions
19
Other Managers
0
Confidential Omitted
No
Holdings (19)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VERONA PHARMA PLC | 925050106 | 63,499 | $4.0M | 19.32% |
| 2 | SUMMIT THERAPEUTICS INC | SMMT | 124,307 | $2.4M | 11.49% |
| 3 | JANUX THERAPEUTICS INC | JANX | 78,500 | $2.1M | 10.16% |
| 4 | REGENERON PHARMACEUTICALS | REGN | 2,600 | $1.6M | 7.90% |
| 5 | NEUROCRINE BIOSCIENCES INC | NBIX | 13,612 | $1.5M | 7.21% |
| 6 | INSMED INC | INSM | 19,192 | $1.5M | 7.02% |
| 7 | SOLENO THERAPEUTICS INC | SLNO | 19,858 | $1.4M | 6.80% |
| 8 | JAZZ PHARMACEUTICALS PLC | JAZZ | 9,853 | $1.2M | 5.86% |
| 9 | AKERO THERAPEUTICS INC | 00973Y108 | 19,925 | $806,564 | 3.87% |
| 10 | ARGENX SE | ARGX | 1,146 | $678,277 | 3.25% |
| 11 | ELI LILLY & CO | LLY | 816 | $673,943 | 3.23% |
| 12 | PROTAGONIST THERAPEUTICS INC | PTGX | 12,859 | $621,861 | 2.98% |
| 13 | TG THERAPEUTICS INC | TGTX | 13,500 | $532,305 | 2.55% |
| 14 | TARSUS PHARMACEUTICALS INC | TARS | 7,076 | $363,494 | 1.74% |
| 15 | ASCENDIS PHARMA A/S | ASND | 2,173 | $338,684 | 1.62% |
| 16 | RHYTHM PHARMACEUTICALS INC | RYTM | 6,277 | $332,493 | 1.59% |
| 17 | BIONTECH SE | BNTX | 3,000 | $273,180 | 1.31% |
| 18 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 5,897 | $260,235 | 1.25% |
| 19 | COGENT BIOSCIENCES INC | COGT | 29,491 | $176,651 | 0.85% |